Osteopore Limited (ASX:OSX)

Australia · Delayed Price · Currency is AUD

0.0040

-0.0010 (-20.00%)

Aug 11, 2026, 10:25 AM AEST

-63.64% (1Y)

Market Cap	3.13M +20.0%
Revenue (ttm)	3.06M +10.7%
Net Income	-3.72M
EPS	-0.02
Shares Out	626.36M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,810
Open	0.0040
Previous Close	0.0050
Day's Range	0.0040 - 0.0040
52-Week Range	0.0040 - 0.0290
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Osteopore

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and tra... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2003

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol OSX

Full Company Profile

Financial Performance

In 2025, Osteopore's revenue was 3.06 million, an increase of 10.65% compared to the previous year's 2.76 million. Losses were -3.72 million, 11.0% more than in 2024.

Financial Statements